Discovery of Novel <i>N</i> -Linked Camptothecin Linker-Payloads to Access Antibody–Drug Conjugates with High Target-Mediated In Vivo Efficacy

-aminobenzyl carbamate (PABC) linkers with a focus on stability and polarity leads to the discovery of promising α-amino-isobutyramido-exatecan constructs. The corresponding high-DAR ADCs showed low aggregation, good in vitro potency, and robust target-mediated efficacy in vivo across two antibody-antigen pairs. These results demonstrate the potential of these linker-payloads and the broad applicability of this design strategy.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-04-30
DOI
https://doi.org/10.1021/acs.jmedchem.5c03693
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of Novel N -Linked Camptothecin Linker-Payloads to Access Antibody–Drug Conjugates with High Target-Mediated In Vivo Efficacy

Vlad Bacauanu, Esther Kofman, Ryan V. Quiroz, Laurence Fayadat‐Dilman et al.
Journal of Medicinal Chemistry
HER2/EGFR in Cancer Research
article

Discovery of Novel N -Linked Camptothecin Linker-Payloads to Access Antibody–Drug Conjugates with High Target-Mediated In Vivo Efficacy

Vlad Bacauanu, Esther Kofman, Ryan V. Quiroz, Laurence Fayadat‐Dilman, Simon B. Lang, Bernhard H. Geierstanger, Zhong L. Hua, Michael Judo, Alan B. Northrup, Ian Knemeyer, Christian L. Morales, Daniela M. Tomazela, Manoj B. Charati, Nancy Zepeda, John A. Flygare, Mengxuan Jia, Si-Jie Chen, Rebecca Johnson, Evan R. Barry, Song Yang, Qingyun Yan, Peyman Akbari, Edward P. Bowman, Olivia R Chastain, W Michael Seganish, Alycia K Uyeoka, Fan Zhang
article en

Abstract

-aminobenzyl carbamate (PABC) linkers with a focus on stability and polarity leads to the discovery of promising α-amino-isobutyramido-exatecan constructs. The corresponding high-DAR ADCs showed low aggregation, good in vitro potency, and robust target-mediated efficacy in vivo across two antibody-antigen pairs. These results demonstrate the potential of these linker-payloads and the broad applicability of this design strategy.

Journal of Medicinal Chemistry
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Openalex Percentile: Top 14%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.